Drug expiry debate: the myth and the reality - African Health Science Assessment report: Ozempic - European Medicines Agency Exploring beyond numeric weight loss: The metabolic effects of semaglutide - Clinical nutrition ESPEN Expiration Dates - FDA Insulin Storage: A Critical Reappraisal - Journal of Diabetes Science & Technology Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages - Clinical Diabetes, American Diabetes Association APIC position paper: Safe injection, infusion, and medication vial practices in health care - American Journal of Infection Control
On TikTok, Reddit, and some telehealth websites, microdosing glucagon-like peptide-1 (GLP-1) receptor agonist medications is pitched as a gentler, more flexible way to use drugs such as the GLP-1 agonist semaglutide (Ozempic, Wegovy), the dual GIP/GLP-1 agonist tirzepatide (Mounjaro, Zepbound), and oral nonpeptide GLP-1 receptor agonist orforglipron (Foundayo)
If you also have an overactive thyroid as the underlying cause of your tremor, see your endocrinologist before starting Mounjaro, as significant weight loss can change how much thyroid hormone you need
J Bone Miner Res (2013) 28(7):164152
These risks and others described in the Risk Factors section of each of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and any of our subsequent filings with the Commission may not be exhaustive